1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Spinal Fractures

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Spinal Fractures in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, SH; Kim, BJ; Kim, H; Koh, JM; Lee, SH	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Spinal Fractures

Article	Year
Higher plasma platelet-activating factor levels are associated with increased risk of vertebral fracture and lower bone mineral density in postmenopausal women. Journal of bone and mineral metabolism, 2015, Volume: 33, Issue:6 Topics: Aged; Alkaline Phosphatase; Bone Density; Case-Control Studies; Female; Humans; Middle Aged; Odds Ratio; Platelet Activating Factor; Postmenopause; Risk Factors; Spinal Fractures	2015

Article

Year

Higher plasma platelet-activating factor levels are associated with increased risk of vertebral fracture and lower bone mineral density in postmenopausal women.

Journal of bone and mineral metabolism, 2015, Volume: 33, Issue:6

Topics: Aged; Alkaline Phosphatase; Bone Density; Case-Control Studies; Female; Humans; Middle Aged; Odds Ratio; Platelet Activating Factor; Postmenopause; Risk Factors; Spinal Fractures

2015